AstraZeneca Investors May Focus on Next-Year Outlook After Q3 Results
Bank of America analysts say investors might shift focus to AstraZeneca’s outlook for next year after the company reported better-than-expected third-quarter results and left full-year guidance unchanged.
Story updates
12:44:14 PM UTC
SquawkNews
AstraZeneca's Investments Prevent Guidance Raise — Market Talk